Tag: NeuraLace
Neuralace announces upcoming SEAT trial presentation among other clinical milestones
Neuralace Medical has announced the upcoming clinical study presentation of the SEAT randomised controlled trial (RCT), which is assessing the safety and efficacy of...
Neuralace enrols first patients in AT-PDN study evaluating Axon therapy
Neuralace Medical has announced the commencement of and first patient enrolments in its AT-PDN (Axon therapy and painful diabetic neuropathy) study.
The multicentre AT-PDN study...
NeuraLace announces two new patents for Axon neuropathic pain therapies
NeuraLace Medical has announced the expansion of its global patent portfolio with the issuance of two new patents: US Patent No. 11,305,130 for "Devices, systems,...
